Ацетилсалициловая кислота у пациентов перед плановыми хирургическими вмешательствами
- Авторы: Алтарев С.С.1, Барбараш О.Л.1
-
Учреждения:
- ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний
- Выпуск: Том 6, № 3 (2015)
- Страницы: 48-57
- Раздел: Статьи
- URL: https://ogarev-online.ru/2221-7185/article/view/45153
- DOI: https://doi.org/10.26442/CS45153
- ID: 45153
Цитировать
Полный текст
Аннотация
Полный текст
Открыть статью на сайте журналаОб авторах
Сергей Сергеевич Алтарев
ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний
Email: altarev@inbox.ru
канд. мед. наук, ст. науч. сотр. лаб. реабилитации отд. мультифокального атеросклероза ФГБНУ НИИ КПССЗ 650002, Россия, Кемерово, Сосновый б-р, д. 6
Ольга Леонидовна Барбараш
ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний
Email: olb61@mail.ru
д-р мед. наук, проф., дир. ФГБНУ НИИ КПССЗ 650002, Россия, Кемерово, Сосновый б-р, д. 6
Список литературы
- Roffi M, Patrono C, Collet J-P et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. EHJ 2015. doi: 10.1093/eurheartj/ehv320
- Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
- Mangano D.T. Perioperative cardiovascular morbidity: new developments. Best Pract Res Clin Anaesthesiol 1999; 13 (3): 335-48.
- Vicenzi M.N, Meislitzer T, Heitzinger B et al. Coronary artery stenting and non - cardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96: 686-93.
- Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug - eluting stents. J Am Med Assoc 2005; 293: 2126-30.
- Patrono C, Baigent C, Hirsh J et al. Аntiplatelet Drugs. Chest 2008; 133 (6 Suppl.): 199S-233S.
- Awtry E.H, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18.
- Jimenez A.H, Stubbs M.E, Tofler G.H et al. Rapidity and duration of platelet suppression by entericcoated aspirin in healthy young men. Am J Cardiol 1992; 69: 258-62.
- Antithrombotic Trialists’ Collaboration. Collaborative meta - analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
- Hall R, Mazer C.D. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011; 112: 292-318.
- Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration. BMJ 1994; 308: 81-106.
- Baigent C, Blackwell L, Collins R et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta - analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-60.
- Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). EHJ 2012; 33: 1635-701.
- Amsterdam E.A, Wenger N.K, Brindis R.G et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. Circulation 2014; 130: e344-e426.
- O’Gara P.T, Kushner F.G, Ascheim D.D et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. Circulation 2013; 127: e362-e425.
- Fihn S.D, Gardin J.M, Abrams J et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. JACC 2012; 60 (24): e44-e164.
- Brott T.G, Halperin J.L, Abbara S et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Circulation 2011; 124: e54-e130.
- Rooke T.W, Hirsch A.T, Misra S et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline). Circulation 2011; 124: 2020-45.
- Burger W, Chemnitius J.M, Kneissl G.D et al. Low - dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta - analysis. J Intern Med 2005; 257: 399-414.
- Palmer J.D, Sparrow O.C, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35: 1061-4.
- Oscarsson A, Gupta A, Fredrikson M et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305-12.
- Kaluza G.L, Joseph J, Lee J.R et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. JACC 2000; 35: 1288-94.
- Sharma A.K, Ajani A.E, Hamwi S.M et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63: 141-5.
- Biondi-Zoccai G.G, Lotrionte M, Agostoni P et al. A systematic review and meta - analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. EHJ 2006; 27: 2667-74.
- Collet J.P, Himbert F, Steg P.G. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000; 76: 257-8.
- Collet J.P, Montalescot G, Balnchet B et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7.
- Ferrari E, Benhamou M, Cerboni P et al. Coronary syndromes following aspirin withdrawal, a special risk for late stent thrombosis. JACC 2005; 45: 456-9.
- Maulaz A.B, Bezerra D.C, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005; 62 (8): 1217-20.
- Sung J.J, Lau J.Y, Ching J.Y et al. Continuation of low - dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010; 152: 1-9.
- Madan G.A, Madan S.G, Madan G et al. Minor oral surgery without stopping daily low - dose aspirin therapy: a study of 51 patients. J Oral Maxillofac Surg 2005; 63: 1262-5.
- Chu M.B, Turner R.B, Kriegel D.A. Patients with drug - eluting stents and management of their anticoagulant therapy in cutaneous surgery. J Am Acad Dermatol 2011; 64: 553-8.
- Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg 2004; 30: 1091-4.
- Cook-Norris R.H, Michaels J.D, Weaver A.L et al. Complications of cutaneous surgery in patients taking clopidogrel - containing anticoagulation. J Am Acad Dermatol 2011; 65: 584-91.
- Douketis J.D, Spyropoulos A.C, Spencer F.A et al. Perioperative Management of Antithrombotic Therapy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141 (2 Suppl.): e326S-e350S.
- Manocha D, Singh M, Mehta N et al. Bleeding Risk after Invasive Procedures in Aspirin/NSAID Users: Polypectomy Study in Veterans. Am J Med 2012; 125: 1222-7.
- Yousfi M, Gostout C.J, Baron T.H et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99: 1785-9.
- Hui A.J, Wong R.M, Ching J.Y et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59: 44-8.
- Anderson M.A, Ben-Menachem T, Gan S.I et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009; 70: 1060-70.
- Lindblad B, Persson N.H, Takolander R et al. Does low - dose acetylsalicylic acid prevent stroke after carotid surgery? A double blind, placebo - controlled randomized trial. Stroke 1993; 24: 1125-8.
- Neilipovitz D.T, Bryson G.L, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93: 573-80.
- Rosenbaum A, Rizvi A.Z, Alden P.B et al. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy. Ann Vasc Surg 2011; 25: 25-31.
- Burdess A, Nimmo A.F, Garden O.J et al. Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg 2010; 252: 37-42.
- Eng M, Brock G, Li X et al. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transplant 2011; 25: 292-6.
- Giannarini G, Mogorovich A, Valent F et al. Continuing or discontinuing low - dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. Urology 2007; 70: 501-5.
- Halliwell O.T, Yadegafar G, Lane C et al. Transrectal ultrasound - guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications. Clin Radiol 2008; 63: 557-61.
- Thurston A.V, Briant S.L. Aspirin and post - prostatectomy haemorrhage. Br J Urol 1993; 71: 574-6.
- Wierod F.S, Frandsen N.J, Jacobsen J.D et al. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998; 32: 120-2.
- Nielsen J.D, Holm-Nielsen A, Jespersen J et al. The effect of low - dose acetylsalicylic acid on bleeding after transurethral prostatectomy - a prospective, randomized, double - blind, placebo - controlled study. Scand J Urol Nephrol 2000; 34: 194-8.
- Ala-Opas M.Y, Gronlund S.S. Blood loss in long - term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996; 30: 203-6.
- Ferraris V.A, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983; 156: 439-42.
- Ott M.M, Eriksson E, Vanderkolk W et al. Antiplatelet and anticoagulation therapies do not increase mortality in the absence of traumatic brain injury. J Trauma 2010; 68: 560-3.
- Manning B.J, O’Brien N, Aravindan S et al. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 2004; 35: 121-4.
- Anekstein Y, Tamir E, Halperin N et al. Aspirin therapy and bleeding during proximal femoral fracture surgery. Clin Orthop Relat Res 2004; 418: 205-8.
- Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg 2010; 15: 109-13.
- Devereaux P.J, Mrkobrada M, Sessler D.I et al. Aspirin in Patients Undergoing Noncardiac Surgery. N Engl J Med 2014; 370 (16): 1494-503.
- Fleisher L.A, Fleischmann K.E, Auerbach A.D et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary. Circulation 2014; 130: 2215-45.
- Ghaffarinejad M.H, Fazelifar A.F, Shirvani S.M et al. The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery. Cardiol J 2007; 14: 453-7.
- Srinivasan A.K, Grayson A.D, Pullan D.M et al. Effect of preoperative aspirin use in off - pump coronary artery bypass operations. Ann Thorac Surg 2003; 76: 41-5.
- Sun J.C, Crowther M.A, Warkentin T.E et al. Should aspirin be discontinued before coronary artery bypass surgery? Circulation 2005; 112: e85-e90.
- Preisman S, Kogan A, Itzkovsky K et al. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 2010; 37: 1367-74.
- Gulbins H, Malkoc A, Ennker I.C et al. Preoperative Platelet Inhibition with ASA Does Not Influence Postoperative Blood Loss Following Coronary Artery Bypass Grafting. Thorac Cardiovasc Surg 2009; 57 (1): 18-21.
- Bybee K.A, Powell B.D, Valeti U et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112 (Suppl. 1): I-286-I-292.
- Bélisle S, Hardy J.F. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996; 62: 1908-17.
- Vuylsteke A, Oduro A, Cardan E et al. Effects of aspirin in coronary artery bypass grafting. J Cardiothorac Vasc Anaesth 1997; 11: 831-4.
- Sun J.C.J, Whitlock R, Cheng J et al. The effect of pre - operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 2008; 29: 1057-71.
- Hillis D.L, Smith P.K, Anderson J.L et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation 2011; 124: e652-e735.
- Weil J, Colin-Jones D, Langman M et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-30.
- Chan F.K, Ching J.Y, Hung L.C et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005; 352: 238-44.
- Weisman S.M, Graham D.Y. Evaluation of the Benefits and Risks of Low-Dose Aspirin in the Secondary Prevention of Cardiovascular and Cerebrovascular Events. Arch Intern Med 2002; 162: 2197-202.
- Savon J.J, Allen M.L, Di Marino A.J.Jr et al. Gastrointestinal blood loss with low dose (325 mg) plain and enteric - coated aspirin administration. Am J Gastroenterol 1995; 90: 581-5.
- Dammann H.G, Burkhardt F, Wolf N. Enteric coating of aspirin signifcantly decreases gastroduodenal mucosal lesions Aliment. Pharmacol Ther 1999; 13 (8): 1109-14.
- Walker J, Robinson J, Stewart J et al. Does enteric - coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Interact Cardiovasc Thorac Surg 2007; 6: 519-22.
- Моисеев В.С. Польза и риск антитромботических средств в профилактике сердечно - сосудистых заболеваний. Клин. фармакология и терапия. 2008; 17 (3): 19-24.
- Endo H, Sakai E, Higurashi T et al. Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy. Dig Liver Dis 2012; 44 (10): 833-8.
- Баркаган З.С., Момот А.П., Котовщикова Е.Ф. и др. Выбор препаратов и мониторинг эффективности антитромботических средств. В кн.: Острый коронарный синдром: проблемы патогенеза, диагностики, классификации, терапии. Томск, 2001; с. 192-4.
- Cox D, Maree A.O, Dooley M et al. Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers. Stroke 2006; 37: 2153-8.
- Maree A.O, Curtin R.J, Dooley M et al. Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease. JACC 2005; 47: 1258-63.
- Grosser T, Fries S, Lawson J.A. Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin. Circulation 2013; 127 (3): 377-85.
- Bode-Böger S.M, Böger R.H, Schubert M et al. Effects of very low dose and enteric - coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects. Eur J Clin Pharmacol 1998; 54 (9-10): 707-14.
- Van Hecken A, Juliano M.L, Depré M et al. Effects of enteric - coated, low - dose aspirin on parameters of platelet function. Aliment Pharmacol Ther 2002; 16: 1683-8.
- ISIS-2 (Second International Study Of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 332 (8607): 349-60.
- Аверков О.В. Ацетилсалициловая кислота как антитромбоцитарное средство: какие лекарственные формы препарата предпочтительны с позиций доказательной медицины? Кардиоваск. терапия и профилактика. 2010; 9 (2): 61-8.
- Jacobs E.J, Thun M.J, Bain E.B et al. A large cohort study of long - term daily use of adult - strength aspirin and cancer incidence. J Natl Cancer Inst 2007; 99: 608-15.
- Ishikawa H, Mutoh M, Suzuki S et al. The preventive effects of low - dose enteric - coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut 2014; 63 (11): 1755-9.
Дополнительные файлы
